Petros Grivas, MD, PhD, board-certified oncologist at the Seattle Cancer Care Alliance (SCCA), director of the University of Washington (UW) School of Medicine’s Genitourinary Cancers Program, and a UW professor of Oncology, spoke with CancerNetwork® about the COVID-19 and Cancer Consortium (CCC19) registry data presented at the 2020 ASCO Annual Virtual Science Program, which reported data from patients with cancer who have tested positive for coronavirus disease 2019 (COVID-19).
Moving forward, Grivas indicated that there are a lot of questions that he and his colleagues have regarding the impact of COVID-19 on patients with cancer. He suggested that with the accumulation of a larger sample size in the future, the answers to some of the questions surrounding COVID-19 will become clearer.
Transcription:
It’s hard to predict the future always, but as always with higher sample…
